A clinical pathway for community-acquired pneumonia: an observational cohort study

Simple item page
dc.creatorFrei, Christopher R.en
dc.creatorBell, Allison M.en
dc.creatorTraugott, Kristi A.en
dc.creatorJaso, Terry C.en
dc.creatorDaniels Kelly R.en
dc.creatorMortensen, Eric M.en
dc.creatorRestrepo, Marcos I.en
dc.creatorOramasionwu, Christine U.en
dc.creatorRuiz, Andres D.en
dc.creatorMylchreest, William R.en
dc.creatorSikirica, Vanjaen
dc.creatorRaut, Monika R.en
dc.creatorFisher, Alanen
dc.creatorSchein, Jeff R.en
dc.date.accessioned2014-12-15T17:09:51Zen
dc.date.available2014-12-15T17:09:51Zen
dc.date.issued2011-07-06en
dc.descriptionChristopher R Frei, Allison M. Bell, Kristi A. Traugott, Terry C. Jaso, Kelly R. Daniels, Christine U. Oranasionwu, and Andres D. Ruiz are with the College of Pharmacy, The University of Texas at Austin, 1 University Station A1900, Austin TX, 78712, USA -- Christopher R. Frei, Allison M. Bell, Kristi A. Traugott, Kelly R. Daniels, Christine U. Oramasionwu, and Andres D. Ruiz are with the Pharmacotherapy Education and Research Center, School of Medicine, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, Mail Code 6220, San Antonio, TX, 78229-3900, USA -- Kristi A. Traugott is with the Department of Pharmacy, South Texas Veterans Healthcare System, ALMD/UTHSCSA, 7400 Merton Minter Boulevard, San Antonio, TX, 78229, USA -- Terry C. Jaso and William R. Mylchreest are with the Seton Family of Hospitals, P.O. Box 201233, Austin, TX, 78720-1233, USA -- Kelly R. Daniels and Andres D. Ruiz are with the Oakdell Pharmacy, Inc., 7220 Louis Pasteur Drive, Suite 176, San Antonio, TX, 78229, USA -- Eric M. Mortensen and Marcos I. Restrepo are with the Department of Medicine, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229-3900, USA -- Marcos I. Restrpo is with VERDICT, South Texas Veterans Healthcare System, ALMD/UTHSCSA, Ambulatory Care (11C6), 7400 Merton Minter Boulevard, San Antonio, TX, 78229, USA -- Monika R. Raut, Alan Fisher, and Jeff R. Schein are with Ortho-McNeil Janssen Scientific Affairs, LLC, 1000 Route 202, P.O. Box 300, Raritan, NJ, 08869, USAen
dc.description.abstractBackground: Six hospitals instituted a voluntary, system-wide, pathway for community acquired pneumonia (CAP). We proposed this study to determine the impact of pathway antibiotics on patient survival, hospital length of stay (LOS), and total hospital cost. Methods: Data were collected for adults from six U.S. hospitals with a principal CAP discharge diagnosis code, a chest infiltrate, and medical notes indicative of CAP from 2005-2007. Pathway and non-pathway cohorts were assigned according to antibiotics received within 48 hours of admission. Pathway antibiotics included levofloxacin 750 mg monotherapy or ceftriaxone 1000 mg plus azithromycin 500 mg daily. Multivariable regression models assessed 90-day mortality, hospital LOS, total hospital cost, and total pharmacy cost. Results: Overall, 792 patients met study criteria. Of these, 505 (64%) received pathway antibiotics and 287 (36%) received non-pathway antibiotics. Adjusted means and p-values were derived from Least Squares regression models that included Pneumonia Severity Index risk class, patient age, heart failure, chronic obstructive pulmonary disease, and admitting hospital as covariates. After adjustment, patients who received pathway antibiotics experienced lower adjusted 90-day mortality (p = 0.02), shorter mean hospital LOS (3.9 vs. 5.0 days, p < 0.01), lower mean hospital costs ($2,485 vs. $3,281, p = 0.02), and similar mean pharmacy costs ($356 vs. $442, p = 0.11). Conclusions: Pathway antibiotics were associated with improved patient survival hospital LOS and total hospital cost for patients admitted to the hospital with CAP.en
dc.description.catalogingnotefreic@uthscsa.eduen
dc.description.departmentPharmaceutical Sciencesen
dc.description.sponsorship;en
dc.identifier.Filename1471-2334-11-188en
dc.identifier.citationFrei, Christopher R., Allison M. Bell, Kristi A. Traugott, Terry C. Jaso, Kelly R. Daniels, Eric M. Mortensen, Marcos I. Restrepo, et al. “A Clinical Pathway for Community-Acquired Pneumonia: An Observational Cohort Study.” BMC Infectious Diseases 11, no. 1 (July 6, 2011): 188. doi:10.1186/1471-2334-11-188.en
dc.identifier.doidoi:10.1186/1471-2334-11-188en
dc.identifier.urihttp://hdl.handle.net/2152/27799en
dc.language.isoEnglishen
dc.publisherBMC Infectious Diseasesen
dc.rightsAdministrative deposit of works to UT Digital Repository: This works author(s) is or was a University faculty member, student or staff member; this article is already available through open access at http://www.biomedcentral.com. The public license is specified as CC-BY: http://creativecommons.org/licenses/by/4.0/. The library makes the deposit as a matter of fair use (for scholarly, educational, and research purposes), and to preserve the work and further secure public access to the works of the University.en
dc.subjectcommunity-acquired pneumoniaen
dc.subjectpathway antibioticsen
dc.subjectpatient survivalen
dc.titleA clinical pathway for community-acquired pneumonia: an observational cohort studyen
dc.typeArticleen

Access full-text files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
1471-2334-11-188.pdf
Size:
263.89 KB
Format:
Adobe Portable Document Format
Download

Collections

UT Faculty/Researcher Works